Pfizer Q3 FY26: where the revenue came from and where it went
The whole income statement of Pfizer for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jun 29 – Sep 27, 2026
- Reported
- Nov 3, 2026
Revenue$16.6B
+0% year over year
Gross profit$12.6B
76% margin
Operating profit−$3.4B
−20% margin
Net profit$3.2B
20% margin
Net profit is larger than what operations earned, because the statement adds $6.8B below it, under Other income, net.
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 16.6 | 100% | +0% |
| US | 10.6 | 64% | −1% |
| Developed markets | 3.6 | 22% | −1% |
| International emerging | 2.3 | 14% | +3% |
| Cost of revenue | −4.0 | 24% | |
| Gross profit | 12.6 | 76% margin | +1pp |
| SG&A | −3.3 | 20% | +1pp |
| Other | −12.7 | 76% | +0pp |
| Operating profit | −3.4 | −20% margin | |
| Other income, net | 6.8 | ||
| Tax | −0.1 | ||
| Net profit | 3.2 | 20% margin | −2pp |
4 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest